Working… Menu

A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00921895
Recruitment Status : Completed
First Posted : June 16, 2009
Results First Posted : August 24, 2012
Last Update Posted : November 24, 2015
Information provided by (Responsible Party):
RapidPS ( Rapid Pathogen Screening )

Brief Summary:
To engage in a multi-center, prospective, masked clinical trial to investigate a non-invasive, rapid diagnostic test, the RPS Adeno Detector IV's ability to detect the presence of the adenovirus (ADV) antigen in cases of acute conjunctivitis by comparing it to cell culture with confirmatory immunofluorescence (CC-IFA). The polymerase chain reaction (PCR) will be used as a referee for discrepant cases.

Condition or disease Intervention/treatment Phase
Conjunctivitis Device: RPS Adeno Detector IV Not Applicable

Detailed Description:
The RPS Adeno Detector IV will show substantial equivalence to cell culture for diagnosing adenoviral conjunctivitis.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 128 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Comparison of the Sensitivity and Specificity of the RPS Adeno Detector IV™ at Detecting the Presence of Adenovirus to Viral Cell Culture.
Study Start Date : June 2009
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pinkeye

Arm Intervention/treatment
Experimental: Device Testing
Patients with conjunctivitis will be tested with the RPS Adeno Detector IV
Device: RPS Adeno Detector IV
One time test with the RPS Adeno Detector IV

Primary Outcome Measures :
  1. Sensitivity and Specificity of RPS Adeno Detector IV Compared to Cell Culture. [ Time Frame: 15 minutes ]
    Sensitivity is proportion of true positive cases compared to cell culture. Specificity is the proportion of true negative cases compared to cell culture.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • A total of 150 patients will be enrolled and who present prospectively to either a private practice or academic center with a presumed diagnosis of acute viral conjunctivitis while an internal review board (IRB) approved ophthalmologist is available and determined by the ophthalmologist to have met the following criteria for the clinical diagnosis of acute viral conjunctivitis will be included in the study.
  • Criteria for clinical diagnosis of viral conjunctivitis. Requires that patients are at least 1 month old and present within 7 days of developing a red eye with at least 1 criteria from each of the 3 categories below:

I History: 1) Spread from 1 eye to the other several days later, 2) a recent history of an upper respiratory infection (URI)

II Signs: 1) presence of follicles, 2) presence of a preauricular node

III Symptoms: 1) watery - purulent discharge, 2) eyelash matting, 3) itching, or 4) foreign body sensation

Exclusion Criteria:

  • Patients with allergy to corn starch, talcum powder, or dacron will be excluded.
  • Patients with a corneal ulcer or history of recent trauma will also be excluded.
  • Any patients who are using any topical ointment (including OTC artificial tear ointments) in the last 72 hours should be excluded.
  • Patients using other topical ophthalmic medications (i.e. antibiotics) must allow 60 minutes prior to device application following any topical ophthalmic drops.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00921895

Layout table for location information
United States, Florida
Manatee Eye Clinic
Bradenton, Florida, United States, 34208
Center For Excellence in Eye Care
Miami, Florida, United States, 33176
United States, Missouri
St John's Clinic
Springfield, Missouri, United States, 65804
United States, New York
Ophthalmic Consultants of Long Island
Lynbrook, New York, United States, 11563
Weill-Cornell Medical College
New York, New York, United States, 10021
South Shore Eye Care
Wantagh, New York, United States, 11793
United States, Pennsylvania
Wills Eye Institute
Philadelphia, Pennsylvania, United States, 19107
Northeastern Eye Institute
Scranton, Pennsylvania, United States, 18503
Sponsors and Collaborators
Rapid Pathogen Screening
Layout table for investigator information
Principal Investigator: Shachar Tauber, MD St John's Clinic
Principal Investigator: Jodi Luchs, MD South Shore Eye Clinic
Principal Investigator: William Trattler, MD Center For Excellence In Eye Care
Principal Investigator: Thomas Boland, MD Northeastern Eye Institute
Principal Investigator: Michael DellaVecchia, MD/PhD Wills Eye Institute
Principal Investigator: Murray Friedberg, MD Manatee Eye Clinic
Principal Investigator: Chris Starr, MD Weill Medical College of Cornell University
Principal Investigator: Marguerite McDonald, MD Ophthalmic Consultants of Long Island
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Rapid Pathogen Screening Identifier: NCT00921895    
Obsolete Identifiers: NCT00799318
Other Study ID Numbers: 200-003
First Posted: June 16, 2009    Key Record Dates
Results First Posted: August 24, 2012
Last Update Posted: November 24, 2015
Last Verified: October 2015
Keywords provided by RapidPS ( Rapid Pathogen Screening ):
Pink Eye,
Viral conjunctivitis
Adenoviral conjunctivitis
Additional relevant MeSH terms:
Layout table for MeSH terms
Conjunctival Diseases
Eye Diseases